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The purpose of the National Children’s Study
(NCS) is to evaluate the health risks to chil-
dren in this country from environmental
exposures by using a longitudinal cohort
design (Children’s Health Act of 2000). This
effort is expected to improve our children’s
health by mitigating these health risks in our
society. The approach of the NCS is to cen-
tralize its activities around hypotheses that
evaluate the relationship between a wide array
of environmental exposures (i.e., chemical,
biologic, physical, and psychosocial factors)
and priority health outcomes. The list of pri-
ority outcomes includes pregnancy, neuro-
developmental injury, asthma, and obesity
and physical development. One of several
NCS hypotheses addressing these concerns
seeks to evaluate the effects of environmental
agents on the age at puberty, which was dis-
cussed at an inter-work group meeting co-
chaired by the Nutrition, Growth, and
Pubertal Development Working Group and
the Exposure to Chemical Agents Working
Group (Baltimore, Maryland, 17–18 December
2002). This article presents a brief back-
ground on the factors associated with the age
of maturity and discusses the assessment for
exposure to environmental chemical agents in
the developing child by using a life-stage
approach. The articles in this mini-mono-
graph describe the roles and efforts of the
Exposure to Chemical Agents Working
Group in the NCS. Portions of this discussion
may refer the reader to these other articles for
additional information.
Recent evidence suggests that puberty in
U.S. children is starting at an earlier age com-
pared with previous years (Anderson et al.
2003; Freedman et al. 2003; Herman-
Giddens et al. 1997, 2001). This is of general
interest because the extent to which this is
occurring in this population has not been well
characterized and because such ﬁndings have
potential influences within our society. In
cross-sectional studies of populations in the
United States from 1988 through 1994, it is
reported that the mean age of onset for breast
development for girls was 9.5–9.7 years,
which is approximately 1–2 years earlier than
the observations of previous investigators (Lee
et al. 2001). This approximates to 14% of the
population achieving Tanner stage 2 or
greater for breast development at the age of
8 years (Lee et al. 2001). In U.S. boys sampled
from 1988 through 1994, the median age of
onset for genital development ranged from 9.5
to 10.4 years, depending on race/ethnicity,
which is about 1 year earlier than that previ-
ously described (Herman-Giddens et al.
2001). This corresponded to about 32–58%
of the boys attaining Tanner stage 2 at 9 years
of age. These observed changes in pubertal
development are not unique to the United
States but also have been noted in other coun-
tries (Huen et al. 1997; Karlberg 2002; Parent
et al. 2003; Proos et al. 1993; Viner 2002).
To define properly the significance of these
findings to the population, more refined
investigations are needed to characterize the
time trend in pubertal development because
of the limitations in study design of these
prior reports (Lee et al. 2001; Reiter and Lee
2001; Viner 2002). Nutrition, genetic pre-
disposition, and environmental chemical
exposure are factors associated with pubertal
change that can be evaluated during this
process.
The factors associated with altered puber-
tal development are numerous (Parent et al.
2003). When early onset of puberty was origi-
nally noted in immigrant children, it was
attributed to improved nutrition and well-
being. Although these remain the primary fac-
tors determining the onset and progression of
puberty, there are other considerations. These
include genetic predisposition or host suscep-
tibility, and environmental chemical exposure.
Certain populations may be susceptible to
variations in pubertal development base on
observations among racial/ethnic groups
(Anderson et al. 2003; Freedman et al. 2002;
Sun et al. 2002; Wu et al. 2002). African-
American girls were reported to develop either
thelarche or pubarche at about the mean age
of 8.8 years, 1–2 years earlier than non-
Hispanic white girls (Herman-Giddens et al.
1997). This trend in race/ethnic groups for
the age of onset for puberty was noted in boys
as well (Herman-Giddens et al. 2001; Sun
et al. 2002). Although obesity was associated
with the early onset of puberty in these
racial/ethnic groups, it was less of a determin-
ing variable in African-American girls, sug-
gesting the involvement of other factors
(Kaplowitz et al. 2001). In a study of serum
leptin levels in girls 8–17 years of age, African-
Americans girls were noted to have higher lep-
tin levels than Caucasians after controlling for
obesity, age, and serum insulin levels (Wong
et al. 1998). Although serum leptin was
shown to increase before gonadotropin levels
in girls and boys (Garcia-Mayor et al. 1997),
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opment of puberty is not known, and further
work is necessary to define this mechanism
and the difference in leptin levels among
racial/ethnicity groups (Danadian et al. 1999;
Ruhl et al. 2004).
The early onset of puberty is clinically and
socially important to the population. The early
onset of thelarche is associated with an early
diagnosis of breast cancer in susceptible popu-
lations (Hamilton and Mack 2003) and adult
obesity (Biro et al. 2003). Breast cancer is asso-
ciated with an early age of onset of menarche
as well. Girls attaining menarche after 13 years
of age were observed to have a one-third
decreased risk [multivariate relative risk = 0.66;
95% conﬁdence interval (CI), 0.44–0.99] for
breast cancer compared with those attaining
menarche at a younger age (Garland et al.
1998). This effect also was characterized by
deﬁning a 2-year delay in the age of menarche
to a 10% decrease in risk for breast cancer
(Hsieh et al. 1990). These observations imply
the need for additional surveillance for these
measures because they can affect diagnostic
evaluation (Chalumeau et al. 2002; Dorn et al.
1999; Kaplowitz and Oberfield 1999). The
social consequence is that children will need to
learn how to adapt to their maturing bodies at
an earlier age, and our public school system
will need to re-evaluate the timing and struc-
ture of health education classes because the
early onset of puberty has been associated with
risky and unhealthy behaviors (Orr and
Ingersoll 1995; Simon et al. 2003).
Environmental Chemicals
Several environmental chemicals are known to
have hormonal activity, and their effects
are well demonstrated in animal studies
(Goldman et al. 2000; Stoker et al. 2000). The
hormonal effects of these chemicals can be
categorized by estrogenic, antiestrogenic,
androgenic, antiandrogenic, and thyroidal
activities. Depending on a chemical’s hor-
monal activity, onset of puberty may be either
delayed or accelerated. There is also experi-
mental evidence demonstrating that chemical
exposures during gestation can result in altered
mammary gland development (Nikaido et al.
2004; Rayner et al. 2004) and age of pubertal
onset (Casanova et al. 1999; Nikaido et al.
2004; Tou et al. 1998). The effects of these
chemicals on the growth, development, and
reproductive health of people are largely
unknown because this remains a relatively new
area of investigation. The chemical class that is
best described in this area is polychlorinated
biphenyls (PCBs). PCBs and their hydroxy-
lated metabolites are known for their effects
on the thyroid regulatory pathway, which can
affect neurodevelopment (Jacobson and
Jacobson 1996; Meerts et al. 2002). In addi-
tion to PCBs, several other chemicals with
hormonal activity are associated with health
effects after exposure, some of which are dis-
cussed below (Table 1). (Note that the discus-
sion of these chemicals does not imply that the
NCS has determined that these chemicals
either cause these health effects or will be
included in the NCS.)
Environmental lead was recently observed
to be associated with delayed age of onset of
puberty in girls in the United States (Selevan
et al. 2003; Wu et al. 2003). In a cross-
sectional survey of 1,706 girls 8 through
16 years of age during 1988 through 1994,
increased blood lead level was associated with a
decreased likelihood for the attainment of
either pubarche or menarche but not thelarche
(Wu et al. 2003). Girls with lead levels in the
ranges of 2.1–4.9 and 5–21.7 µg/dL were
approximately 50 and 80%, respectively, less
likely to reach these measures of puberty than
those with lead levels between 0.7 and
2.0 µg/dL. In younger girls (8 through 12 years
of age), the percentage of girls attaining pub-
arche by age decreased with increasing blood
lead levels. When the same population was
analyzed by racial/ethnicity groups, a higher
blood lead level (3 vs. 1 µg/dL) in African-
American girls was associated with delayed
onset of pubarche, thelarche, and menarche by
2–4 months (Selevan et al. 2003). There also
was a decreased likelihood of approximately
60% for the attainment of a successive Tanner
stage for breast and pubic hair development in
African-American girls. Similar delays in the-
larche and pubarche were observed in
Mexican-American girls, except the delays were
smaller in magnitude. No differences in blood
lead levels were observed in pubertal outcomes
in non-Hispanic white girls. Underlying differ-
ences in growth or hormonal regulation among
the racial/ethnic groups may explain the
observed pubertal effects in association with
lead exposure (Wong et al. 1998).
Chronic exposure to lead was demon-
strated to affect the hypothalamo–pituitary–
gonadal axis by altering serum levels of
gonadotropic and androgenic hormones. In
occupationally exposed males, prolonged lead
exposure at the workplace was associated with
decreased serum testosterone (Rodamilans
et al. 1988). Serum luteinizing hormone
levels were found to be lower both in occupa-
tional males (McGregor and Mason 1990)
and in children 11 through 13 years of age
from the general population (Vivoli et al.
1993) with high lead levels. The effects of
exposure to environmental lead on the levels
of estrogens, androgens, and gonadotropins in
younger children and their pubertal develop-
ment remain to be determined. Future studies
in this area need to pay particular attention
to the timing of exposure during develop-
ment and the contribution of race/ethnicity
to such ﬁndings.
The effects of the exposure to persistent
organohalogen chemicals on maturation have
been evaluated in several epidemiologic investi-
gations. Two studies evaluated the contribu-
tion of in utero and postnatal exposure to these
chemicals. Polybrominated biphenyls (PBBs)
were found to be associated with premature
thelarche in girls who were breast-fed by moth-
ers with high serum PBB levels (≥ 7 µg/L)
resulting from exposure to milk from cows
given contaminated feed (Blanck et al. 2000).
However, in girls who were not breast-fed by
their PBB-exposed mothers, the maternal
serum PBB level was not associated with early
breast development, thus suggesting the contri-
bution of postnatal exposure to altered pubertal
development in this setting. There also was an
increased risk (adjusted hazard ratio, 3.70; 95%
CI, 1.41–9.71) for the earlier onset of menar-
che in girls breast-fed by mothers with high
serum PBB levels compared with girls who
were not breast-fed by mothers with low serum
PBB levels (less than or equal to limit of detec-
tion). In the North Carolina Infant Feeding
Study (1978 through 1982), in utero exposure
to either PCBs or 1,1´-(2,2-dichloroethenyli-
dene)-bis[4-chlorobenzene] [p,p´-DDE, a
metabolite of dichlorodiphenyltrichloroethane
(p,p´-DDT)] was not associated with the time
to attainment of the Tanner stages in boys and
girls (Gladen et al. 2000). However, increasing
human milk levels of PCBs and p,p´-DDE
were associated with increased body weight in
girls and boys, respectively. Other studies evalu-
ating the effects of exposure to PCBs and
dioxin-like compounds (Den Hond et al.
2002) and to endosulfan (Saiyed et al. 2003)
on the timing of pubertal milestones found
either no effects or delayed effects, which var-
ied by gender. These latter reports were limited
by either the contribution of potential risk fac-
tors (e.g., congenital disorders) to the ﬁndings
or their inability to relate their ﬁndings to pre-
natal versus postnatal exposure because the par-
ticipants were evaluated only during puberty.
Finally, nonpersistent chemicals such as
phthalates (Colon et al. 2000) and phyto-
estrogens have been investigated for their
association with altered time of onset of
puberty as well. Phytoestrogens are naturally
occurring environmental chemicals found in
fruits, vegetables, and legumes (e.g., soybeans)
and have notable estrogenic activity. In a
case–control study, the intake of soy-based
formula was associated with an increased like-
lihood of premature thelarche in children
younger than 2 years but not in children diag-
nosed with thelarche beyond this age (Freni-
Titulaer et al. 1986). This suggests that
various factors were most likely contributing
to early breast development in this study
population, depending upon the age of onset
of the disorder. In both these areas of investi-
gation, additional work is needed to clarify
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these earlier findings because of either their
small sample sizes or the current availability of
improved methodology (e.g., biomonitoring)
in exposure assessment.
Despite the ﬁndings of the various studies
presented in the preceding section, the extent
to which environmental chemicals contribute
to changes in human pubertal development
remains largely unknown. This is because of
limitations in the designs of the investigations
from which these observations were made, the
various approaches used in conducting expo-
sure assessment, and the few number of
chemicals studied to date that are related to
populations. A focused investigation could
attempt to answer some of the questions
regarding environmental chemical exposure
and maturation. For example, what is the sig-
niﬁcance to pubertal development of the tim-
ing of exposure to a chemical during a child’s
growth? Current studies in this area do not
allow for such conclusions because of cross-
sectional or retrospective design.
The observations from either cross-
sectional or retrospective study designs are dif-
ﬁcult to interpret as to the timing of chemical
exposure during a child’s development, and use
less than perfect models to assess for overall
exposure when a single level of a chemical in a
biologic matrix is available. An example of
when the latter situation becomes challenging
is with human milk. When infant exposure is
assessed from human milk consumption, both
the changing level of the chemical in the milk
during the breast-feeding period and the
duration of breast-feeding must be considered.
The timing of exposure to a chemical is
extremely difficult to ascertain from these
study designs. This is because the random sam-
pling of blood or urine from an individual does
not allow for a determination of when the
exposure occurred, which could have been at
any time before the procurement of the speci-
men. However, exposures to apparent events
(e.g., the industrial chemical explosion in
Table 1. Human studies on the effects of environmental chemical exposure on pubertal development.
Developmental
window or route of Associated health effects
Chemical Reference exposure assessed Exposure measure Level of exposure Males Females
p,p’-DDE Gladen et al.  Intrauterine Milk level at birth Median, 2.4 µg/g lipids No effect on attainment  No effect on time of
2000 Range, 0.3–23.8 µg/g lipids of puberty by DDE level onset, height, or body
from intrauterine weight at puberty by
exposure DDE level from
Increased height and intrauterine exposure
body weight at puberty
with increasing DDE
level from intrauterine
exposure
Postnatal  Lactational exposure  No effect on attainment of
(breastfeeding) index puberty by DDE level from
lactational exposure
Krstevska- Puberty Serum level at or  Immigrant/adopted, 1.04 µg/L  Immigrant children with idiopathic precocious
Konstantinova  postpuberty (median) puberty had higher DDE levels than native children
et al. 2001 Immigrant/nonadopted, with precocious puberty; adoption status was not
1.20 µg/L (median)  associated with DDE level
Native, 0.13 µg/L (median)
Dioxin-like  Den Hond et al. Puberty Serum level at  Exposures: range of means, No effect on likelihood Decreased likelihood to
compounds 2002  puberty 0.11–0.21 ng TEQ/L to attain either genital  attain thelarche with
maturity or pubarche increasing TEQ level
by TEQ level
Endosulfan Saiyed et al.  Puberty Serum level at  Exposed, 7.47 ± 1.19 µg/L Delayed pubarche and
2003 puberty (mean ± SD) genital maturity with
Nonexposed, 1.37 ± 0.40 µg/L exposure
(mean ± SD)
Lead Selevan et al. Puberty Blood level at Non-Hispanic whites: No effect on pubarche,
2003 puberty geometric mean, 1.4 µg/dL;  menarche, or thelarche
95% CI, 1.2–1.5 by lead level for non-
Hispanic whites
African Americans: Delayed pubarche,
geometric mean, 2.1 µg/dL;  thelarche, and menarche
95% CI, 1.9–2.3 with increasing lead level
for African Americans
Mexican Americans:  Delayed pubarche and
geometric mean, 1.7 µg/dL,  thelarche with increasing
95% CI, 1.6–1.9 lead level for Mexican 
Americans
Decreased height with
increasing lead level,
regardless of
race/ethnicity
Wu et al. Puberty Blood level at Range, 0.7–21.7 µg/dL Delayed pubarche 
2003 puberty and menarche with
increasing lead level,
no effect on attainment
of thelarche by lead
level
PBBs Blanck et al.  Intrauterine Extrapolated Mean ± SD, 17.3 µg/L ± 107.8;  Accelerated attainment of
2000 maternal serum  range, NDa to 1,142 µg/L menarche with increasing
level posteventb intrauterine PBB level
and breast-feeding
Continued, next pageSeveso, Italy, in 1976) in combination with
elevated levels are exceptions. Timing is more
of a problem for a persistent chemical with a
long half-life than for a nonpersistent chemical.
This problem can make it difficult to assess
either the occurrence of subacute exposures or
the source of the exposure when location has
changed. The lack of consideration for these
concerns can lead to either misclassiﬁcation of
a study participant for a critical window of
exposure, or increased variance in the popula-
tion for a given effect. Additional concerns
with these types of designs for investigating
health effects include the difﬁculty in establish-
ing a temporal relation between exposure and
effect and the introduction of recall bias when
collecting information from the participants.
These study design issues are best resolved
with a prospective longitudinal design, which
can be accomplished for environmental chem-
icals during the evaluation of other factors
more closely associated with pubertal develop-
ment. The assessment for exposure in this set-
ting may be more resource intensive than in
the aforementioned designs, but this can be
reduced by constructing nested case–control
studies. Nutrition and genetic predisposition
are important contributors to growth and
maturity, which require further investigations.
Although it is generally accepted that nutrition
affects pubertal development, unresolved issues
remain because this association is variable
among studies, and recent evidence suggests
that birth size contributes to puberty as well
(Luo et al. 2003). The extent to which birth
height and body mass index relate to nutritional
status in determining the timing of puberty is
not known. As more work is done to resolve
such questions, it would be important to con-
trol for environmental chemical exposure.
Strategies for Testing
Hypotheses
Sampling Periods
The timing for the collection of exposure data
(environmental, questionnaire, and biologic)
depends on two general factors: the health
effect being monitored and the environmental
chemical that is under evaluation. In the
evaluation of sexual maturation, it is important
to monitor for the formative periods of the sex-
ual organs (in utero) when a signiﬁcant amount
of chemical exposure is expected, that is, post-
natal (breast-feeding), pre- and peripuberty,
and the completion of puberty. These are dis-
cussed to a greater extent elsewhere (Pryor
et al. 2000). Recruitment of participants dur-
ing preconception will ensure that exposures in
the ﬁrst trimester of gestation will be character-
ized, and data collected at this time may serve
as a baseline comparison throughout the
pregnancy and the postpartum period.
The successful completion of sexual matu-
ration is dependent on proper anatomic devel-
opment of the organs and hormonal regulation
leading to their function. The anatomic devel-
opment of organs and sexual differentiation of
the fetus occurs during pregnancy or the
in utero period. Organogenesis takes place
in the ﬁrst trimester (weeks 4–8) of gestation,
and disruption during this time can lead to
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Table 1. Continued
Developmental
window or route of Associated health effects
Chemical Reference exposure assessed Exposure measure Level of exposure Males Females
PCBs Blanck et al. Intrauterine Maternal serum  Mean ± SD, 5.6 µg/L ± 5.5;  No effect on age at
2000 level posteventb range, NDc to 78 µg/L menarche or attainment 
of thelarche or pubarche 
by intrauterine PCB level
Den Hond et al. Puberty Serum level at Exposures: range of PCB-138 Decreased likelihood to No effect on likelihood to
2002 puberty means, 94–227 ng/L attain genital maturity attain either thelarche 
with increasing PCB-138 or pubarche by PCB-138 
level level
Exposures: range of PCB-153 Decreased likelihood to No effect on likelihood to
means, 166–332 ng/L attain pubarche with attain either thelarche 
increasing PCB-153 or pubarche by PCB-153 
level level
Exposures: range of PCB-180 No effect on likelihood No effect on likelihood to
means, 95–202 ng/L to attain either genital attain either thelarche
maturity or pubarche or pubarche by PCB-180
by PCB-180 level level
Gladen et al. Intrauterine Milk level at birth Median, 1.7 µg/g lipids,  No effect on time of onset  No effect on time of
2000 Range, 0.5–5.5 µg/g lipids of puberty or height or  onset of puberty by PCB
body weight at puberty level from intrauterine
by PCB level from exposure
intrauterine exposure Increased body weight at
puberty with increasing
PCB level from
intrauterine exposure in
Caucasian girls
Postnatal Lactational exposure No effect on time of onset  No effect on time of
(breastfeeding) index of puberty or height or  onset, height, or body
body weight at puberty  weight at puberty by
by PCB level from PCB level from
lactational exposure lactational exposure
Phthalates Colon et al. Puberty Serum level at Cases: DEHP, 450 µg/L Premature thelarche
2000 puberty (mean ± SD not given)
Controls: DEHP, 70 µg/L
(mean ± SD not given)
Phytoestrogens Freni-Titulaer Puberty Questionnaire Use of soy-based formula
et al. 1986 increased likelihood for
onset of premature
thelarche before 
2 years of age
Abbreviations: DEHP, di-(2-ethylhexyl) phthalate; ND, not detected; p,p’-DDE, p,p', dichlorodiphenyldichloroethylene; TEQ, toxic equivalent.
aPBB limit of detection, 1 µg/L. bCows contaminated by feed containing PBB in 1973. cPCB limit of detection, 5 µg/L.disorders that may be apparent at birth or not
apparent until adulthood. Some notable exam-
ples of this include diethylstilbestrol (DES) and
thalidomide. DES was used in the early 1940s
and 1950s for the treatment of irregular vagi-
nal bleeding and threatened abortions. DES is
associated with the occurrence of cervical or
vaginal clear-cell adenocarcinoma in the F1
generation when exposure was before 18 weeks
of gestation (Hatch et al. 1998). Thalidomide
was used in the late 1950s to treat nausea and
vomiting associated with pregnancy, causing
severe limb malformations in the newborn
when exposure occurred during days 34–50 of
gestation (Smithells and Newman 1992). The
in utero exposure to various stimuli leading to
altered pubertal development was demon-
strated in animal experiments using intra-
uterine artery ligation and chemical treatments.
Intrauterine ligation during gestation was used
to simulate malnutrition in a rat model and
was shown to cause a delay in the onset of
puberty in males and females (Engelbregt et al.
2000). Bisphenol A (Howdeshell et al. 1999)
and octylphenol (Bogh et al. 2001; Wright
et al. 2002) treatments in animals were demon-
strated to advance puberty by shortening the
time to either the ﬁrst estrus or its equivalent.
For example, the gilts of sows treated with
octylphenol from days 23–85 of gestation were
observed to have a shorter period to first
estrous compared with controls (mean ± SD,
211.5 ± 14.5 days vs. 246.0 ± 36.7 days)
(Bogh et al. 2001). However, octylphenol did
not alter testicular size in boars that were
exposed to octylphenol as fetuses (Bogh et al.
2001). When ewes were treated with octyl-
phenol from day 70 of gestation to birth, the
times to the dates of ﬁrst estrous and ﬁrst prog-
esterone rise in the lambs were decreased com-
pared with controls by an average of about
20 days and 44 days, respectively (Wright et al.
2002). In the same study the lambs of ewes
treated through birth and to weanling had
shorter times to puberty compared with
controls as well, but they were not different
from lambs from ewes treated to birth.
Atrazine delayed mammary gland development
in female rats treated either as fetuses during
gestational days 15–19 or during lactation
(Rayner et al. 2004). In the same model,
vaginal opening was delayed only in rat pups
that were exposed to atrazine by lactation.
Phytoestrogens, such as genistein (Casanova
et al. 1999) and the lignan-containing ﬂaxseed
(Tou et al. 1998), advanced the time of onset
of puberty in female rats when high doses were
initiated during the gestational period and
continued postnatally. Of note, when ﬂaxseed
was administered at a lower dose, it delayed the
onset of puberty (Tou et al. 1998). No
observed pubertal effects (i.e., time of onset, tes-
ticular weight) were found in males in these
phytoestrogen models. The effects of in utero
exposure to environmental chemicals on puber-
tal development were evaluated in several epi-
demiologic studies. For PCBs and p,p´-DDE
this route of exposure was compared with that
from breast-feeding in one study (Table 1). The
signiﬁcant difference between these two expo-
sure periods is that the amount of chemical
delivered to the infant from lactation is usually
greater than the amount of chemical delivered
to the fetus by the placenta (Jacobson and
Jacobson 1996). The importance of these
experimental ﬁndings in animals and data on
human exposure to chemicals is that they lend
support to the biologic plausibility or likelihood
that a chemical can either cause or modify the
outcome of the purported health effect. It will
be important to consider mechanisms of
action, timing of exposure, and existing chemi-
cal levels in the general population from back-
ground exposure when candidate chemicals are
reviewed for this hypothesis.
During the in utero period, the fetus
should be assessed for exposures that coincide
with the developmental windows of the pri-
mary and secondary sexual organs (Pryor et al.
2000) (Table 2). For example, mammary
Wang et al.
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Table 2. Sampling periods for the assessment of exposure to persistent and nonpersistent chemicals.
Postpartum Prepuberty
Preconceptiona In utero Perinatal (18–24 months) (5–6 years) Midpuberty Postpuberty
Persistent chemicals
Urineb,c,d M/F M (10–15 weekse)M x x x x
Serumb,f M/F M (10–15 weekse)M x x x x
Whole bloodb,f M/F M (10–15 weekse)M x x x x
Hairb M
Human milkb 2 weeks – 2 months postpartum
Cord serumb x
Cord whole bloodb x
Meconiumb x
Dietary assessmentg x M (10–15 weekse)x x x x x
Home air sampleb,g  xxx x x x x
Home composite dust sampleb,g xxx x x x x
Other environmental samplesb,g  Special studies Special studies Special studies Special studies Special studies Special studies Special studies
Questionnaireg x x x —— At 6, 12, 24 and 36 months, then annually until puberty —— 
Ecologic analysis (e.g., GIS)g xxx x x x x
Nonpersistent chemicals
Urineb,c,d M/F M (10–15 weekse)M x x x x
Serumb,f M/F M (10–15 weekse)M x x x x
Human milkb 2 weeks – 2 months postpartum
Cord serumb x
Meconiumb x
Dietary assessmentg x M (10–15 weekse)x x x x x
Home air sampleb,g xxx x x x x
Home composite dust sampleb,g xxx x x x x
Other environmental samplesb,g Special studies Special studies Special studies Special studies Special studies Special studies Special studies
Questionnaireg x x x —— At 6, 12, 24 and 36 months, then annually until puberty —— 
Ecologic analysis (e.g., GIS)g xxx x x x x
GIS, geographic information system; F, father; M, mother; x, period when samples are to be collected.
aAt the time of enrollment. bMedia with extant laboratory methods for likely target chemical agent. Note that for nonpersistent chemicals, multiple samples of biologic specimens may be
needed during this time because of possible variability in biologic exposure level due to the short half-life of the chemical. This is particularly important if a critical exposure period is
being considered. Alternatively, pilot data may demonstrate the lack of need for frequent sampling if constant exposure occurred in a stable environment. cTimed specimen collection;
morning void specimen with creatinine measurement. dPediatric urine bag or diaper sample for non-toilet-trained children. If not diaper, spot samples or multiple spots. eFor example,
weeks 10–15 of gestation are a critical period for breast development. fWhen blood collection is at a young age, piggyback on lead screen at 12 and 24 months that is recommended by
the Centers for Disease Control and Prevention. gEnvironmental sampling, dietary assessment, questionnaires, and ecologic analysis are necessary for persistent chemicals to deter-
mine either route or pathway of exposure; otherwise, exposure can be established through the analysis of biologic specimens. Information should be obtained proximate to the sampling
period for biologic specimens.gland development begins at about week 4
and continues through week 10 of gestation.
The primary mammary bud is formed during
this period. From weeks 10 through 15 of ges-
tation, formation of secondary buds, the nip-
ple, and the areola occurs. The critical window
of development for the external genitalia is
from weeks 7 through 12 of gestation. Because
it is important to assess for exposure during
this early period of gestation, it is recom-
mended to recruit study participants before
conception to ensure that this critical period
during gestation is not missed.
Once the sexual organs are formed, their
activation for reproduction is determined by
hormonal (gonadotropins, estrogens, andro-
gens) regulation. In females this is largely deter-
mined by estrogenic activity and in males, by
androgens. In the prepubertal female, estrogen
levels are low and stable until puberty, when a
surge in estrogen level occurs, resulting from
gonadotropin stimulation. The pituitary gland
begins to secrete luteinizing hormone at
approximately 1–3 years before the onset of
puberty. The prepubertal period is an impor-
tant time to assess for environmental chemical
exposure because of several reported cases of
girls developing premature thelarche after being
exposed to estrogen compounds (Teilmann
et al. 2002). Thus, the sampling would include
in utero (gestation), postnatal (for breast-feeding
infants), before puberty (pre- and peripuberty),
and postpuberty (or the completion) periods.
It is important to monitor puberty to its com-
pletion because the time of onset of puberty
and the duration for its completion may vary
independently. Further deﬁnitions of the fre-
quency for monitoring during the prepubescent
period may be gained from reviewing longitudi-
nal studies on puberty (Biro et al. 1995; Lee
1980; Roche et al. 1995).
Populations with High Exposures
Certain populations that may be susceptible or
vulnerable to environmental chemical exposure
will need to be considered in the study design.
The reasons are variable and include genetic
predisposition, nutrition, and socioeconomic
factors. For example, persons frequently ingest-
ing ﬁsh or whale meals are likely to have ele-
vated levels of PCBs, polychlorinated
dibenzo-p-dioxins (PCDDs), and polychlori-
nated dibenzofurans (PCDFs). This was
observed in persons residing near the Great
Lakes region of the United States and members
of the Inuit tribe in Canada. Children residing
in homes built before 1946 were found to have
approximately a 5-fold increased incidence of
blood lead levels ≥ 10 µg/dL compared with
children residing in homes built after 1973
(Pirkle et al. 1998). Low-income status and
African-American race/ethnicity were associated
with elevated blood lead levels (≥ 10 µg/dL) in
families living in homes built before 1946.
Environmental Chemicals
Many environmental chemicals are observed
to have endocrine or hormonal activity
(National Research Council 1999). However,
only a few of these chemicals are associated
with effects on the age at puberty in humans,
including lead (Selevan et al. 2003; Wu et al.
2003), PBBs (Blanck et al. 2000), PCBs
(Den Hond et al. 2002; Gladen et al. 2000),
PCDDs/PCDFs (Den Hond et al. 2002),
p,p´-DDT/p,p´-DDE (Gladen et al. 2000;
Krstevska-Konstantinova et al. 2001), endo-
sulfan (Saiyed et al. 2003), phthalates (Colon
et al. 2000), and phytoestrogens (Freni-
Titulaer et al. 1986). To encompass all these
chemicals into the assessment strategy, the
chemicals can be categorized as either biologi-
cally persistent or nonpersistent (Table 2).
Generally, persistent chemicals have long half-
lives (months to years) and are measured in
the blood. Although this may seem advanta-
geous from a sampling perspective (i.e., wide
window of opportunity), it does pose a chal-
lenge when critical windows of exposure are of
concern and when subacute exposures may
have occurred. Thus, if exposure occurs dur-
ing critical periods of a child’s development,
then specimens should be obtained proximate
to those periods. Questionnaires and environ-
mental assessment would be necessary if the
pathways of exposure are important, because
biologic monitoring would not be able to
identify the exposure pathway or the exposure
location. For example, the presence of a persis-
tent chemical in the blood of a person who
recently moved to a new location would most
likely represent an exposure from the former
location. However, this would not be known
by the blood test alone. If documentation of
exposure of a persistent chemical is all that is
necessary, then biologic monitoring should be
adequate. Nonpersistent chemicals have short
half-lives (hours to days) and are usually meas-
ured in the urine. For nonpersistent organic
chemicals, increased reliance is needed on
questionnaires and environmental samples to
document exposure. This is because of the
relatively short time that these chemicals exist
in the body.
Measurements
Exposure assessment. The choice of the biologic
matrix to measure for the chemicals is largely
determined by the properties of the chemical
(e.g., lipid solubility, protein-binding capacity,
and ionic charge), which governs the distribu-
tion of the chemical in the body. Blood and
urine are the standard specimens used for the
measurement of chemicals, and water-soluble
chemicals are commonly quantiﬁed in urine.
In addition, the target organ or organism needs
to be considered. For example, if the interest is
in fetal exposure, then cord blood is the pre-
ferred specimen. If the route of exposure is
important, for example, identify either the
source of exposure or the degree to which one
source may be more important in determining
a health outcome. If two sources are involved,
then several matrices will have to be sampled.
For example, an infant’s exposure can occur
either during the in utero period through the
placenta or during breast-feeding. However,
neither the amount of chemical exposure nor
the determined health effect is consistent by
either of these routes of exposure. In the case of
PCB exposure, it was determined that breast-
feeding contributed to a larger amount of expo-
sure to the infant than did placental transfer;
however, the latter was deemed more conse-
quential to delayed neurodevelopment
(Jacobson and Jacobson 1996). If the extent to
which a chemical partitions into various bio-
logic matrices is known, then alternative speci-
mens may be used if the desired specimen is not
adequate. For example, maternal blood, cord
blood, and maternal milk may be used to assess
for fetal exposure to persistent organic chemi-
cals. The assessment of the infant to exposure to
chemicals from human milk requires multiple
milk samplings during the breast-feeding period
because of the expected decline in the level of
persistent chemicals in human milk from
maternal depuration. Additional consideration
is needed to characterize the difference between
infants who are exclusively breast-fed and those
who are partially breast-fed because the volume
of milk intake will vary by these practices of
breast-feeding. Meconium is a biologic matrix
that is currently under investigation as an indi-
cator of chemical exposure. The interest in this
matrix is because of its potential to reflect
chemical exposures to the fetus as early as the
second trimester.
Researchers may need to customize ques-
tionnaires and environmental sampling based
on the use patterns of particular classes of
chemicals. Phthalates, for example, are
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Table 3. Health effect measures to assess for puber-
tal development.a
Onset of puberty
Sexual maturity rating (Tanner staging)
Performed by observer or by self-reporting
Frequency: annually
Stature
Hormones [luteinizing hormone, estradiol, testosterone, 
dehydroepiandrostendione-sulfate (DHEA-S)]
Salivary hormone levels
Thyroid-stimulating hormone
Later stages of puberty
Voice pattern change (males)
Menarche
Menstrual history
Dual-energy X-ray absorptiometry
At age 6 and 12 years for females and at age 6 and 
14 years for males
aDiscussed at the NCS inter-work group meeting “Obesity
and Physical Development.” This meeting was co-chaired
by the Nutrition, Growth, and Pubertal Development and
the Exposure to Chemical Agents working groups in
Baltimore, Maryland (USA), on 17–18 December 2002.commonly found in personal care products
(e.g., cosmetics, shampoos); therefore,
researchers should ask specific questions
regarding the use of these products (Tiwary
and Ward 2003). Similarly, changes in loca-
tion throughout the life stages (home, school,
work site) may warrant adjustments of these
assessment tools. In the design of these expo-
sure assessment tools, it is important to vali-
date them before applying them to health
effect studies.
Biologic markers of health effect. These
measurements will be used to monitor the
onset and completion of puberty. Various
tools can be used, including biochemical
measures (e.g., hormones), physical examina-
tion, and diagnostic scans (Rockett et al.
2004) (Table 3). Dual-energy X-ray absorp-
tiometry is a noninvasive method to assess
body fat mass, body fat-free mass, and bone
mineral mass and density for skeletal maturity.
Potential Risk Factors for Altered
Pubertal Development
Several factors are known to cause or are associ-
ated with altered pubertal development that
need to be considered in the study because
they may bias the estimate of the relationship
between chemical exposure and the age of
onset of puberty. Some of these items are listed
in Table 4.
Conclusion
Evidence exists that nutritional status, genetic
predisposition (race/ethnicity), and environ-
mental chemical exposure are associated with
altered age at puberty. The assessment for
exposure to environmental chemicals that may
affect the attainment of puberty in the develop-
ing child is challenged by several factors, includ-
ing the various developmental periods when an
exposure can affect the maturation process, lim-
ited access to certain biologic specimens during
select periods of human development, and the
many chemicals with varying properties. The
recommended approach is to conduct the
assessment by life stages (i.e., in utero, postnatal,
pre- and peripubertal). Study participants need
to be recruited at preconception to ensure that
the “critical window” of gestation, that is, the
first trimester, is included in the exposure
assessment process. Chemicals should be cate-
gorized by biologic persistence, and biologic
specimens that are most likely to yield mean-
ingful information should be collected and
stored. The latter will allow for the judicious
use of specimens of limited quantity for special
investigations (e.g., nested case–control studies)
and time to develop new and improved analyti-
cal methods. For chemicals that either cannot
be measured in biologic specimens or have
short biologic half-lives, the analysis of environ-
mental samples and use of questionnaire data
are necessary to complete the assessment for
exposure. Food and dietary data may assist in
determining the extent to which nutrients and
chemicals from this pathway contribute to the
variance in the timing of puberty. Factors that
are either known causes of, or associated with,
altered pubertal development need to be con-
trolled for during the assessment of health out-
comes. The National Children’s Study is
uniquely poised to evaluate the effects of envi-
ronmental chemicals on the age at puberty, and
the above approach will allow the NCS to
accomplish this task.
REFERENCES
Anderson SE, Dallal GE, Must A. 2003. Relative weight and race
influence average age at menarche: results from two
nationally representative surveys of US girls studied
25 years apart. Pediatrics 111(4 pt 1):844–850.
Biro FM, Lucky AW, Huster GA, Morrison JA. 1995. Pubertal
staging in boys [published erratum J Pediatr 127:674].
J Pediatr 127:100–102. 
Biro FM, Lucky AW, Simbartl LA, Barton BA, Daniels SR,
Striegel-Moore R, et al. 2003. Pubertal maturation in girls
and the relationship to anthropometric changes: pathways
through puberty. J Pediatr 142:643–646.
Blanck HM, Marcus M, Tolbert PE, Rubin C, Henderson AK,
Hertzberg VS, et al. 2000. Age at menarche and Tanner
stage in girls exposed in utero and postnatally to poly-
brominated biphenyl. Epidemiology 11:641–647.
Bogh IB, Christensen P, Dantzer V, Groot M, Thofner IC,
Rasmussen RK, et al. 2001. Endocrine disrupting compounds:
effect of octylphenol on reproduction over three genera-
tions. Theriogenology 55:131–150.
Casanova M, You L, Gaido KW, Archibeque-Engle S, Janszen
DB, Heck HA. 1999. Developmental effects of dietary
phytoestrogens in Sprague-Dawley rats and interactions
of genistein and daidzein with rat estrogen receptors
alpha and beta in vitro. Toxicol Sci 51:236–244.
Chalumeau M, Chemaitilly W, Trivin C, Adan L, Breart G,
Brauner R. 2002. Central precocious puberty in girls: an evi-
dence-based diagnosis tree to predict central nervous sys-
tem abnormalities. Pediatrics 109:61–67.
Children’s Health Act of 2000. Public Law 106–310, 2000.
Colon I, Caro D, Bourdony CJ, Rosario O. 2000. Identiﬁcation of
phthalate esters in the serum of young Puerto Rican girls with
premature breast development. Environ Health Perspect
108:895–900.
Danadian K, Suprasongsin C, Janosky JE, Arslanian S. 1999.
Leptin in African-American children. J Pediatr Endocrinol
Metab 12:639–644.
Den Hond E, Roels HA, Hoppenbrouwers K, Nawrot T, Thijs L,
Vandermeulen C, et al. 2002. Sexual maturation in relation to
polychlorinated aromatic hydrocarbons: Sharpe and
Skakkebaek’s hypothesis revisited. Environ Health Perspect
110:771–776.
Dorn LD, Hitt SF, Rotenstein D. 1999. Biopsychological and cog-
nitive differences in children with premature vs. on-time
adrenarche. Arch Pediatr Adolesc Med 153:137–146.
Engelbregt MJ, Houdijk ME, Popp-Snijders C, Delemarre-van
de Waal HA. 2000. The effects of intra-uterine growth
retardation and postnatal undernutrition on onset of
puberty in male and female rats. Pediatr Res 48:803–807.
Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR,
Berenson GS. 2002. Relation of age at menarche to race,
time period, and anthropometric dimensions: the Bogalusa
Heart Study. Pediatrics 110:1–7.
Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR,
Berenson GS. 2003. The relation of menarcheal age to
obesity in childhood and adulthood: the Bogalusa Heart
Study. BMC Pediatr 3:1–9.
Freni-Titulaer LW, Cordero JF, Haddock L, Lebron G, Martinez R,
Mills JL. 1986. Premature thelarche in Puerto Rico. A search
for environmental factors. Am J Dis Child 140:1263–1267.
Garcia-Mayor RV, Andrade MA, Rios M, Lage M, Dieguez C,
Casanueva FF. 1997. Serum leptin levels in normal children:
relationship to age, gender, body mass index, pituitary-
gonadal hormones, and pubertal stage. J Clin Endocrinol
Metab 82:2849–2855.
Garland M, Hunter DJ, Colditz GA, Manson JE, Stampfer MJ,
Spiegelman D, et al. 1998. Menstrual cycle characteristics
and history of ovulatory infertility in relation to breast can-
cer risk in a large cohort of US women. Am J Epidemiol
147:636–643.
Gladen BC, Ragan NB, Rogan WJ. 2000. Pubertal growth and
development and prenatal and lactational exposure to poly-
chlorinated biphenyls and dichlorodiphenyl dichloroethene.
J Pediatr 136:490–496.
Goldman JM, Laws SC, Balchak SK, Cooper RL, Kavlock RJ. 2000.
Endocrine-disrupting chemicals: prepubertal exposures and
effects on sexual maturation and thyroid activity in the
female rat. A focus on the EDSTAC recommendations. Crit
Rev Toxicol 30:135–196.
Hamilton AS, Mack TM. 2003. Puberty and genetic susceptibility
to breast cancer in a case-control study in twins. N Engl J
Med 348:2313–2322.
Wang et al.
1106 VOLUME 113 | NUMBER 8 | August 2005 • Environmental Health Perspectives
Table 4. Potential risk factors affecting pubertal development.
Precocious
Gonadotropin-dependent (central precocious puberty)
Brain pathology (e.g., hypothalamic hamartoma, tumors, hydocephalus, severe head trauma)
Hypothyroidism, untreated
Gonadotropin-independent precocious puberty
McCune-Albright syndrome in girls
Familial male precocious puberty (testotoxicosis)
Tumors (ovarian, adrenocortical, Leydig cell, chorionic gonadotropin-secreting tumors)
Exogenous pharmaceutical estrogen or androgen use
Isolated premature thelarche, premature pubarche/adrenarche, premature menarche
Delayed
Poor nutrition
Chronic illness
Constitutional growth delay
Intense physical training
General categories associated with altered pubertal development
General nutrition
General health
Brain injury
Obesity
Socioeconomic status
Immigration/adoption
Race/ethnicity
Pharmaceuticals [estrogenic, androgenic, estrogen blocker (i.e., aromatase inhibitors), and androgen blocker 
(e.g., ﬁnasteride, ﬂutamide)]
Genetics
Gestational ageAssessment of environmental chemicals affecting puberty
Environmental Health Perspectives • VOLUME 113 | NUMBER 8 | August 2005 1107
Hatch EE, Palmer JR, Titus-Ernstoff L, Noller KL, Kaufman RH,
Mittendorf R, et al. 1998. Cancer risk in women exposed to
diethylstilbestrol in utero. JAMA 280:630–634.
Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ,
Bhapkar MV, Koch GG, et al. 1997. Secondary sexual char-
acteristics and menses in young girls seen in ofﬁce prac-
tice: a study from the Pediatric Research in Ofﬁce Settings
network. Pediatrics 99:505–512.
Herman-Giddens ME, Wang L, Koch G. 2001. Secondary sexual
characteristics in boys: estimates from the National
Health and Nutrition Examination Survey III, 1988–1994.
Arch Pediatr Adolesc Med 155:1022–1028.
Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom
Saal FS. 1999. Exposure to bisphenol A advances puberty.
Nature 401:763–764.
Hsieh CC, Trichopoulos D, Katsouyanni K, Yuasa S. 1990. Age at
menarche, age at menopause, height and obesity as risk
factors for breast cancer: associations and interactions in
an international case-control study. Int J Cancer 46:796–800.
Huen KF, Leung SS, Lau JT, Cheung AY, Leung NK, Chiu MC.
1997. Secular trend in the sexual maturation of southern
Chinese girls. Acta Paediatr 86:1121–1124.
Jacobson JL, Jacobson SW. 1996. Intellectual impairment in chil-
dren exposed to polychlorinated biphenyls in utero. N Engl J
Med 335:783–789.
Kaplowitz PB, Oberfield SE. 1999. Reexamination of the age
limit for deﬁning when puberty is precocious in girls in the
United States: implications for evaluation and treatment.
Drug and Therapeutics and Executive Committees of the
Lawson Wilkins Pediatric Endocrine Society. Pediatrics
104:936–941.
Kaplowitz PB, Slora EJ, Wasserman RC, Pedlow SE, Herman-
Giddens ME. 2001. Earlier onset of puberty in girls: relation
to increased body mass index and race. Pediatrics 108(2):
347–353. 
Karlberg J. 2002. Secular trends in pubertal development. Horm
Res 57(suppl 2):19–30.
Krstevska-Konstantinova M, Charlier C, Craen M, Du Caju M,
Heinrichs C, de Beaufort C, et al. 2001. Sexual precocity
after immigration from developing countries to Belgium:
evidence of previous exposure to organochlorine pesti-
cides. Hum Reprod 16:1020–1026.
Lee PA. 1980. Normal ages of pubertal events among American
males and females. J Adolesc Health Care 1:26–29.
Lee PA, Guo SS, Kulin HE. 2001. Age of puberty: data from the
United States of America. APMIS 109:81–88.
Luo ZC, Cheung YB, He Q, Albertsson-Wikland K, Karlberg J.
2003. Growth in early life and its relation to pubertal growth.
Epidemiology 14:65–73.
McGregor AJ, Mason HJ. 1990. Chronic occupational lead expo-
sure and testicular endocrine function. Hum Exp Toxicol
9:371–376.
Meerts IA, Assink Y, Cenijn PH, Van Den Berg JH, Weijers BM,
Bergman A, et al. 2002. Placental transfer of a hydroxy-
lated polychlorinated biphenyl and effects on fetal and
maternal thyroid hormone homeostasis in the rat. Toxicol
Sci 68:361–371.
National Research Council. 1999. Hormonally Active Agents in the
Environment. Washington, DC:National Academy Press,
27–54.
Nikaido Y, Yoshizawa K, Danbara N, Tsujita-Kyutoku M, Yuri T,
Uehara N, et al. 2004. Effects of maternal xenoestrogen
exposure on development of the reproductive tract and
mammary gland in female CD-1 mouse offspring. Reprod
Toxicol 18:803–811.
Orr DP, Ingersoll GM. 1995. The contribution of level of cogni-
tive complexity and pubertal timing to behavioral risk in
young adolescents. Pediatrics 95:528–533.
Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J,
Bourguignon JP. 2003. The timing of normal puberty and the
age limits of sexual precocity: variations around the world,
secular trends, and changes after migration. Endocr Rev
24:668–693.
Pirkle JL, Kaufmann RB, Brody DJ, Hickman T, Gunter EW,
Paschal DC. 1998. Exposure of the U.S. population to lead,
1991–1994. Environ Health Perspect 106:745–750.
Proos LA, Karlberg J, Hofvander Y, Tuvemo T. 1993. Pubertal lin-
ear growth of Indian girls adopted in Sweden. Acta Paediatr
82:641–644.
Pryor JL, Hughes C, Foster W, Hales BF, Robaire B. 2000. Critical
windows of exposure for children’s health: the reproductive
system in animals and humans. Environ Health Perspect
108(suppl 3):491–503.
Rayner JL, Wood C, Fenton SE. 2004. Exposure parameters nec-
essary for delayed puberty and mammary gland develop-
ment in Long-Evans rats exposed in utero to atrazine. Toxicol
Appl Pharmacol 195:23–34.
Reiter EO, Lee PA. 2001. Have the onset and tempo of puberty
changed? Arch Pediatr Adolesc Med 155:988–989.
Roche AF, Wellens R, Attie KM, Siervogel RM. 1995. The timing of
sexual maturation in a group of US white youths. J Pediatr
Endocrinol Metab 8:11–18.
Rockett JC, Lynch CD, Buck GM. 2004. Biomarkers for assessing
reproductive development and health. Part 1: pubertal
development. Environ Health Perspect 112:105–112.
Rodamilans M, Osaba MJ, To-Figueras J, Rivera Fillat F, Marques
JM, Perez P, et al. 1988. Lead toxicity on endocrine testicular
function in an occupationally exposed population. Hum
Toxicol 7:125–128.
Ruhl CE, Everhart JE, Ding J, Goodpaster BH, Kanaya AM,
Simonsick EM, et al. 2004. Health, Aging, and Body
Composition Study. Serum leptin concentrations and body
adipose measures in older black and white adults. Am J
Clin Nutr 80:576–583.
Saiyed H, Dewan A, Bhatnagar V, Shenoy U, Shenoy R,
Rajmohan H, et al. 2003. Effect of endosulfan on male
reproductive development. Environ Health Perspect
111:1958–1962.
Selevan SG, Rice DC, Hogan KA, Euling SY, Pfahles-Hutchens
A, Bethel J. 2003. Blood lead concentration and delayed
puberty in girls. N Engl J Med 348:1527–1536.
Simon AE, Wardle J, Jarvis MJ, Steggles N, Cartwright M. 2003.
Examining the relationship between pubertal stage, adoles-
cent health behaviours and stress. Psychol Med 33:1369–1379.
Smithells RW, Newman CG. 1992. Recognition of thalidomide
defects. J Med Genet 29:716–723.
Stoker TE, Parks LG, Gray LE, Cooper RL. 2000. Endocrine-disrupt-
ing chemicals: prepubertal exposures and effects on sexual
maturation and thyroid function in the male rat. A focus on
the EDSTAC recommendations. Endocrine Disrupter
Screening and Testing Advisory Committee. Crit Rev Toxicol
30:197–252.
Sun SS, Schubert CM, Chumlea WC, Roche AF, Kulin HE, Lee PA,
et al. 2002. National estimates of the timing of sexual matu-
ration and racial differences among US children. Pediatrics
110:911–919.
Teilmann G, Juul A, Skakkebaek NE, Toppari J. 2002. Putative
effects of endocrine disrupters on pubertal development in
the human. Best Pract Res Clin Endocrinol Metab 16:105–121.
Tiwary CM, Ward JA. 2003. Use of hair products containing hor-
mone or placenta by US military personnel. J Pediatr
Endocrinol Metab 16:1025–1032.
Tou JC, Chen J, Thompson LU. 1998. Flaxseed and its lignan pre-
cursor, secoisolariciresinol diglycoside, affect pregnancy
outcome and reproductive development in rats. J Nutr
128:1861–1868.
Viner R. 2002. Splitting hairs. Arch Dis Child 86(1):8–10.
Vivoli G, Fantuzzi G, Bergomi M, Tonelli E, Gatto MR, Zanetti F,
et al. 1993. Relationship between low lead exposure and
somatic growth in adolescents. J Expo Anal Environ
Epidemiol 3(suppl 1):201–209.
Wong WW, Nicolson M, Stuff JE, Butte NF, Ellis KJ,
Hergenroeder AC, et al. 1998. Serum leptin concentrations
in Caucasian and African-American girls. J Clin Endocrinol
Metab 83:3574–3677.
Wright C, Evans AC, Evans NP, Duffy P, Fox J, Boland MP, et al.
2002. Effect of maternal exposure to the environmental
estrogen, octylphenol, during fetal and/or postnatal life on
onset of puberty, endocrine status, and ovarian follicular
dynamics in ewe lambs. Biol Reprod 67(6):1734-1740.
Wu T, Buck GM, Mendola P. 2003. Blood lead levels and sexual
maturation in U.S. girls: the Third National Health and
Nutrition Examination Survey, 1988–1994. Environ Health
Perspect 111:737–741.
Wu T, Mendola P, Buck GM. 2002. Ethnic differences in the pres-
ence of secondary sex characteristics and menarche
among US girls: the Third National Health and Nutrition
Examination Survey, 1988–1994. Pediatrics 110:752–757.